News | Mammography | January 16, 2019

U.K. study evaluates more than 11 million screening mammograms

Digital Mammography Increases Breast Cancer Detection

January 16, 2019 — The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study appearing in the journal Radiology.1

Digital mammography was introduced into clinical use more than 15 years ago and has been widely adopted due to the numerous advantages it has over its predecessor, screen film mammography.

“Image quality with digital mammography is improved over that of screen film mammography,” said radiologist and study coauthor Rosalind M. Given-Wilson, MBBS, from St. Georges University Hospitals NHS Foundation Trust in London. “In particular, digital mammography provides the ability to visualize calcifications and see through denser tissue, and it allows the reader to adjust the image.”

Given-Wilson and colleagues assessed digital mammography’s impact on cancer detection using data from the 80 facilities of the English National Health Service Breast Cancer Screening Program. The huge trove of data combined with estimates of digital mammography usage enabled the researchers to measure the effect of digital mammography in 11.3 million screening exams in women between the ages of 45 and 70.

The overall cancer detection rate was 14 percent greater with digital mammography, with substantially higher detection of grade 1 and grade 2 invasive cancers — early-stage cancers that could advance to life-threatening disease if not detected and treated early enough.

At first screening exams for women aged 45 to 52, digital mammography increased the overall detection rate by 19 percent. Importantly, the higher sensitivity of digital mammography did not increase the recall rate — the rate at which women are called back for additional screening based on suspicious results.

“This improvement happened in the absence of other changes in the English screening program, such as a change in recall rate or introduction of computer-aided detection, so we can be clear that the increased rate of detection is due to the change in technology,” Given-Wilson said.

Digital mammography increased the detection of some types of cancers more than others. For instance, digital mammography significantly increased the detection of ductal carcinoma in situ (DCIS), an early-stage cancer confined to the milk ducts of the breast, at both first screens and subsequent screens.

“These results confirm that digital mammography is superior to screen film mammography in finding invasive cancers and DCIS,” Given-Wilson said. “Women are more likely to have a cancer detected with a digital mammogram.”

While digital mammography improved detection of grade 1 and 2 cancers, the researchers found no improvement in the detection of grade 3 invasive cancers. Grade 3 cancers are faster-growing and more likely to spread than grade 1 and 2 cancers.

The researchers are looking at the radiological features of grade 3 cancers on digital mammography to see if optimizing the image for these lesions, which are often nonspecific and ill-defined soft tissue densities, can aid detection. They are also studying the relationship between grade 3 cancers and subsequent interval cancers, or cancers that appear between screenings.

For more information: www.pubs.rsna.org/journal/radiology

Reference

1. Blanks R.G., Wallis M.G., Alison R., et al. Impact of Digital Mammography on Cancer Detection and Recall Rates: 11.3 Million Screening Episodes in the English National Health Service Breast Cancer Screening Program. Radiology, Dec. 11, 2018. https://doi.org/10.1148/radiol.2018181426


Related Content

News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
Subscribe Now